These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3720040)

  • 1. Heparin effect on plasma fibrinogen in the thrombophilic syndrome.
    Singer A
    Clin Cardiol; 1986 Apr; 9(4):A18. PubMed ID: 3720040
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose intermittent heparin therapy decreases plasma fibrinogen levels.
    Engelberg H
    Semin Thromb Hemost; 1991; 17 Suppl 2():219-23. PubMed ID: 1948093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary heart disease, fibrinogen, and plasma heparin neutralising activity.
    O'Brien JR; Etherington MD
    Lancet; 1981 Feb; 1(8218):495-6. PubMed ID: 6110107
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin resistance and plasma fibrinogen in elderly subjects with and without occlusive vascular disease.
    Cotton RC; Shaikh MS; Dent RV
    J Atheroscler Res; 1968; 8(6):959-66. PubMed ID: 5707801
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of hypolipidemic agents on the content of sterol-fibrinogen complexes of the blood in patients with ischemic heart disease].
    Palamarchuk VI; Fedorishko SS
    Vrach Delo; 1989 Jan; (1):39-41. PubMed ID: 2718441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of plasma fibrinogen in coronary artery disease.
    Meade TW
    Int J Cardiol; 1992 Dec; 37(3):424-6. PubMed ID: 1468831
    [No Abstract]   [Full Text] [Related]  

  • 7. Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction.
    Timmis GC; Mammen EF; Ramos RG; Gordon S; Gangadharan V; Hauser AM; Westveer DC; Stewart JR
    Arch Intern Med; 1986 Apr; 146(4):667-72. PubMed ID: 3963947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of the coagulograms of patients with coronary insufficiency according to the age group].
    Gurevich MA; Levantovskaia OM
    Kardiologiia; 1968 Sep; 8(9):78-83. PubMed ID: 5728510
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasma fibrinogen patterns in patients with coronary atherosclerosis.
    Hampton JW; Mantooth J; Brandt EN; Wolf SG
    Circulation; 1966 Dec; 34(6):1098-101. PubMed ID: 5928554
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood coagulation and fibrinolytic system in patients with marked coronary arteriosclerosis].
    Gritsiuk AI; Sopina NV
    Kardiologiia; 1970 Oct; 10(10):9-16. PubMed ID: 4251295
    [No Abstract]   [Full Text] [Related]  

  • 11. Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state.
    Patrassi GM; Toffanin F; Massa G; Schivazappa L; Girolami A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(3):414-25. PubMed ID: 89993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinogen content in blood of patients with disturbances in the coronary blood circulation].
    Guniia SS; Kiseleva LN
    Lab Delo; 1966; 5():266. PubMed ID: 4168945
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fibrinogen serum levels in patients with stable coronary artery disease and acute coronary syndrome].
    Gil M; Zarebiński M; Olszewski R; Adamus J
    Pol Merkur Lekarski; 2000 Aug; 9(50):531-2. PubMed ID: 11081317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen, coronary heart disease and prospective studies.
    Pickart L
    Lancet; 1981 Feb; 1(8218):495. PubMed ID: 6110106
    [No Abstract]   [Full Text] [Related]  

  • 15. [Age characteristics of the changes in the blood coagulation and anticoagulation system in patients with acute coronary insufficiency].
    Sakharchuk II; Parkhotik II
    Kardiologiia; 1970 Oct; 10(10):20-6. PubMed ID: 5504111
    [No Abstract]   [Full Text] [Related]  

  • 16. A rapid, quantitative determination of clottable fibrinogen unaffected by heparin.
    Hershgold EJ; Martin B
    Am J Clin Pathol; 1975 Feb; 63(2):231-6. PubMed ID: 1115033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenetic unity of changes in hemocoagulation, blood fibrinolytic activity and several indices of protein-lipid metabolism in coronary arteriosclerosis and hypertensive disease].
    Agarova EN; Krutovskaia OV; Mikhaĭlovskaia EG
    Kardiologiia; 1970 Oct; 10(10):16-20. PubMed ID: 5504110
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparison of 2 methods for determining fibrinogen in the blood plasma].
    Butylin IuP; Buniak OA
    Lab Delo; 1984; (1):15-6. PubMed ID: 6199555
    [No Abstract]   [Full Text] [Related]  

  • 19. [Non-ST elevation acute coronary syndrome: changes of parameters of hemostasis during and after treatment with unfractionated heparin and enoxaparin].
    Averkov OV; Slavina NN; Dobrovol'skiĭ AB; Gratsianskiĭ NA
    Kardiologiia; 2003; 43(9):28-40. PubMed ID: 14593367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of unfractionated and low molecular weight heparins on plasma levels of hemostatic factors in patients with acute coronary syndromes.
    Vila V; Martínez-Sales V; Réganon E; Peris E; Perez F; Ruano M; Aznar J
    Haematologica; 2001 Jul; 86(7):729-34. PubMed ID: 11454528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.